| Trial ID: | L1709 |
| Source ID: | NCT01448174
|
| Associated Drug: |
Atorvastatin
|
| Title: |
Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Renal Failure Chronic Requiring Hemodialysis|Metabolic Syndrome|Diabetes Mellitus Type 2|Hyperlipidemia
|
| Interventions: |
DRUG: Atorvastatin
|
| Outcome Measures: |
Primary: normalization of serum LDL cholesterol, 30 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Poznan University of Medical Sciences
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
310
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2011-10
|
| Completion Date: |
2014-10
|
| Results First Posted: |
|
| Last Update Posted: |
2014-10-07
|
| Locations: |
BBraun Avitum Dialysis Center, Nowy Tomyśl, Wielkopolska, 64-300, Poland
|
| URL: |
https://clinicaltrials.gov/show/NCT01448174
|
